The Holckner Family CF Impact Grant funds outstanding research that aims to accelerate the delivery of life-extending and life-transforming solutions for people living with cystic fibrosis.

In 2026, a total of $1,300 000 is available to be awarded across all projects. Funding will be offered through two streams:

• Stream A - Seed funding projects: 
  • Up to $300,000 maximum per project
  • To support high potential projects that translate research outcomes into practice or lay the groundwork for future translational research.
• Stream B - Major collaborative projects: 
  • Up to $300,000 maximum per project (with maximum of $600,000 available over 2 years)
  • To accelerate high quality CF research with a clear and feasible pathway to human studies and clinical impact.

To be eligible to apply for funding, the following conditions must be met:

• The applicant must complete and submit the application form by 1 June 2026.
• The application must be led by an applicant who is an Australian permanent resident or citizen, with research to be conducted primarily in Australian-based research facilities.
• The proposal must align with Cure4CF's statement of research priority which can be found here.
• The application must demonstrate meaningful engagement with people affected by cystic fibrosis during the development of the research question and project design.
• Only one application will be considered from each lead Chief Investigator per grant round.

• Email: grants@cure4cf.org